Evidence map›Paper›PMID 22522391›Full record

ArticleGenome research2012

Precision genome engineering with programmable DNA-nicking enzymes.

Eunji Kim, Sojung Kim, Duk Hyoung Kim, Beom-Soon Choi, Ik-Young Choi, Jin-Soo Kim

Abstract read
In one paragraph

Article in Genome research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9.Laboratory investigation; a journal of technical methods and pathology · 2018
    Article
  10. Article
  11. Control of gene editing by manipulation of DNA repair mechanisms.Mammalian genome : official journal of the International Mammalian Genome Society · 2017
    Review
  12. Review
  13. Review
  14. Genome-Editing Technologies: Principles and Applications.Cold Spring Harbor perspectives in biology · 2016
    Review
  15. Genome editing comes of age.Nature protocols · 2016
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Eunji KimNational Creative Research Initiatives Center for Genome Engineering and Department of Chemistry, Seoul National University, 599 Gwanak-ro, Gwanak-gu, Seoul, South Korea.
Sojung Kim
Duk Hyoung Kim
Beom-Soon Choi
Ik-Young Choi
Jin-Soo Kim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc finger nucleases (ZFNs) are powerful tools of genome engineering but are limited by their inevitable reliance on error-prone nonhomologous end-joining (NHEJ) repair of DNA double-strand breaks (DSBs), which gives rise to randomly generated, unwanted small insertions or deletions (indels) at both on-target and off-target sites. Here, we present programmable DNA-nicking enzymes (nickases) that produce single-strand breaks (SSBs) or nicks, instead of DSBs, which are repaired by error-free homologous recombination (HR) rather than mutagenic NHEJ. Unlike their corresponding nucleases, zinc finger nickases allow site-specific genome modifications only at the on-target site, without the induction of unwanted indels. We propose that programmable nickases will be of broad utility in research, medicine, and biotechnology, enabling precision genome engineering in any cell or organism.

Indexed as

Genome, HumanZinc FingersCloning, MolecularDeoxyribonuclease IDeoxyribonucleases, Type II Site-SpecificDNA Breaks, Double-StrandedDNA Breaks, Single-StrandedDNA End-Joining RepairGene TargetingGenetic EngineeringGenetic VectorsHEK293 CellsHumansINDEL MutationSensitivity and SpecificityDeoxyribonuclease IDeoxyribonucleases, Type II Site-Specificendodeoxyribonuclease FokI

Identifiers

PMID22522391
PMCPMC3396373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.